Published in J Magn Reson Imaging on May 01, 2003
MRI measurements of carotid plaque in the atherosclerosis risk in communities (ARIC) study: methods, reliability and descriptive statistics. J Magn Reson Imaging (2010) 1.51
MRI detects increased coronary wall thickness in asymptomatic individuals: the multi-ethnic study of atherosclerosis (MESA). J Magn Reson Imaging (2008) 1.15
Coronary vessel wall evaluation by magnetic resonance imaging in the multi-ethnic study of atherosclerosis: determinants of image quality. J Comput Assist Tomogr (2009) 1.02
Carotid plaque neovascularization and hemorrhage detected by MR imaging are associated with recent cerebrovascular ischemic events. AJNR Am J Neuroradiol (2011) 0.99
Magnetic resonance imaging of atherosclerosis. Eur Radiol (2005) 0.84
Right coronary wall CMR in the older asymptomatic advance cohort: positive remodeling and associations with type 2 diabetes and coronary calcium. J Cardiovasc Magn Reson (2010) 0.83
Coronary magnetic resonance imaging: visualization of the vessel lumen and the vessel wall and molecular imaging of arteriothrombosis. Eur Radiol (2005) 0.79
Impact of T2 decay on carotid artery wall thickness measurements. J Magn Reson Imaging (2012) 0.77
Magnetic resonance imaging of the coronary arteries. Cardiovasc J Afr (2007) 0.75
Atherosclerotic plaque fibrous cap assessment under an oblique scan plane orientation in carotid MRI. Quant Imaging Med Surg (2014) 0.75
A computer-simulation study on the effects of MRI voxel dimensions on carotid plaque lipid-core and fibrous cap segmentation and stress modeling. PLoS One (2015) 0.75
k-t BLAST and k-t SENSE: dynamic MRI with high frame rate exploiting spatiotemporal correlations. Magn Reson Med (2003) 5.81
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA (2012) 5.27
American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr (2004) 4.88
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol (2008) 4.51
Transmit and receive transmission line arrays for 7 Tesla parallel imaging. Magn Reson Med (2005) 4.25
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 4.01
Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation (2008) 3.77
Compressed sensing in dynamic MRI. Magn Reson Med (2008) 3.65
In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J (2004) 3.38
Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation (2003) 3.20
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J (2004) 3.19
Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 3.11
Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology (2007) 2.93
Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol (2008) 2.82
Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging (2012) 2.76
Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy. Circ Cardiovasc Imaging (2011) 2.54
2D SENSE for faster 3D MRI. MAGMA (2002) 2.46
Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease. Am Heart J (2012) 2.42
k-t PCA: temporally constrained k-t BLAST reconstruction using principal component analysis. Magn Reson Med (2009) 2.41
Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation (2008) 2.37
Cardiac SSFP imaging at 3 Tesla. Magn Reson Med (2004) 2.33
Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort. J Am Coll Cardiol (2002) 2.33
Recurrence of atrial fibrillation correlates with the extent of post-procedural late gadolinium enhancement: a pilot study. JACC Cardiovasc Imaging (2009) 2.33
Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur Heart J (2011) 2.32
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 2.23
GABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI. Nat Neurosci (2007) 2.22
Dynamic contrast-enhanced myocardial perfusion MRI accelerated with k-t sense. Magn Reson Med (2007) 2.18
Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue Doppler imaging. Circulation (2002) 2.16
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation (2010) 2.14
Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study. Eur Heart J Cardiovasc Imaging (2012) 2.12
Electrodynamics and ultimate SNR in parallel MR imaging. Magn Reson Med (2004) 2.11
Face perception is mediated by a distributed cortical network. Brain Res Bull (2005) 2.10
"Soap-Bubble" visualization and quantitative analysis of 3D coronary magnetic resonance angiograms. Magn Reson Med (2002) 2.09
Noninvasive visualization of coronary artery endothelial function in healthy subjects and in patients with coronary artery disease. J Am Coll Cardiol (2010) 2.09
Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat Med (2007) 2.08
Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation (2011) 2.04
Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cereb Cortex (2006) 1.87
Cardiovascular magnetic resonance characterization of mitral valve prolapse. JACC Cardiovasc Imaging (2008) 1.87
Preliminary report on in vivo coronary MRA at 3 Tesla in humans. Magn Reson Med (2002) 1.82
Array compression for MRI with large coil arrays. Magn Reson Med (2007) 1.81
Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder. Biol Psychiatry (2007) 1.78
Free-breathing 3 T magnetic resonance T2-mapping of the heart. JACC Cardiovasc Imaging (2012) 1.70
Altered negative BOLD responses in the default-mode network during emotion processing in depressed subjects. Neuropsychopharmacology (2008) 1.69
Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation (2006) 1.69
ProFit: two-dimensional prior-knowledge fitting of J-resolved spectra. NMR Biomed (2006) 1.67
Nkx2.5 homeoprotein regulates expression of gap junction protein connexin 43 and sarcomere organization in postnatal cardiomyocytes. J Mol Cell Cardiol (2003) 1.67
Prevalence of non-cardiac pathology on clinical transthoracic echocardiography. J Am Soc Echocardiogr (2012) 1.67
Correlation of trabeculae and papillary muscles with clinical and cardiac characteristics and impact on CMR measures of LV anatomy and function. JACC Cardiovasc Imaging (2012) 1.66
Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy. Circulation (2009) 1.66
Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation (2009) 1.65
The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression. Arch Gen Psychiatry (2009) 1.61
Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy. J Am Coll Cardiol (2013) 1.60
B1-insensitive T2 preparation for improved coronary magnetic resonance angiography at 3 T. Magn Reson Med (2006) 1.58
Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail (2008) 1.58
Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation (2010) 1.57
ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. J Am Coll Cardiol (2005) 1.56
Off-resonance angiography: a new method to depict vessels--phantom and rabbit studies. Radiology (2008) 1.56
Ventricular myocardial architecture as visualised in postmortem swine hearts using magnetic resonance diffusion tensor imaging. Eur J Cardiothorac Surg (2005) 1.56
In vivo assessment of intraplaque and endothelial fibrin in ApoE(-/-) mice by molecular MRI. Atherosclerosis (2012) 1.56
Clinical feasibility of accelerated, high spatial resolution myocardial perfusion imaging. JACC Cardiovasc Imaging (2010) 1.56
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. J Cardiovasc Magn Reson (2004) 1.54
Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson (2006) 1.54
In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation (2004) 1.53
Accelerating cine phase-contrast flow measurements using k-t BLAST and k-t SENSE. Magn Reson Med (2005) 1.50
Simultaneous B(0)- and B(1)+-map acquisition for fast localized shim, frequency, and RF power determination in the heart at 3 T. Magn Reson Med (2010) 1.50
Optimized and combined T1 and B1 mapping technique for fast and accurate T1 quantification in contrast-enhanced abdominal MRI. Magn Reson Med (2007) 1.48
Local deformation of extraocular muscles during eye movement. Invest Ophthalmol Vis Sci (2009) 1.48
Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol (2009) 1.48
C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation (2002) 1.46
CMR predictors of mitral regurgitation in mitral valve prolapse. JACC Cardiovasc Imaging (2010) 1.45
In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation (2004) 1.45
Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease. Circulation (2002) 1.44
Right Ventricular Volumes and Systolic Function by Cardiac Magnetic Resonance and the Impact of Sex, Age, and Obesity in a Longitudinally Followed Cohort Free of Pulmonary and Cardiovascular Disease: The Framingham Heart Study. Circ Cardiovasc Imaging (2016) 1.42
Low-dimensional-structure self-learning and thresholding: regularization beyond compressed sensing for MRI reconstruction. Magn Reson Med (2011) 1.41
Increased self-focus in major depressive disorder is related to neural abnormalities in subcortical-cortical midline structures. Hum Brain Mapp (2009) 1.40
ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance. Circulation (2005) 1.40
Facility perception of nuclear cardiology accreditation: Results of an Intersocietal Accreditation Commission (IAC) survey. J Nucl Cardiol (2014) 1.39
Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation (2006) 1.38
Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study. Arterioscler Thromb Vasc Biol (2002) 1.38
Diffusion imaging of the in vivo heart using spin echoes--considerations on bulk motion sensitivity. Magn Reson Med (2007) 1.36
Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. J Am Coll Cardiol (2008) 1.35
Right ventricular involvement in hypertrophic cardiomyopathy. Am J Cardiol (2007) 1.35
Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct. Am J Cardiol (2010) 1.34